Parabilis Medicines Inc
NASDAQ:PBLS
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
P
|
Parabilis Medicines Inc
NASDAQ:PBLS
|
US |
|
H
|
Hap Seng Consolidated Bhd
KLSE:HAPSENG
|
MY |
|
I
|
Ianthus Capital Holdings Inc
CNSX:IAN
|
CA |
|
Artec Global Media Inc
OTC:ACTL
|
US |
|
Y
|
Yesil Yapi Endustrisi AS
IST:YYAPI.E
|
TR |
|
O
|
Oriental Holdings Bhd
KLSE:ORIENT
|
MY |
|
M
|
Matsa Resources Ltd
XMUN:KB2
|
AU |
|
C
|
Cascade Copper Corp
F:91O
|
CA |
|
A
|
Astra Graphia Tbk PT
XMUN:IUA
|
ID |
|
N
|
Neptune Co
KOSDAQ:217270
|
KR |
|
L
|
Logindo Samudramakmur Tbk PT
IDX:LEAD
|
ID |
|
D
|
DocGo Inc
NASDAQ:DCGO
|
US |
|
Galan Lithium Ltd
ASX:GLN
|
AU |
Valor intrínseco
No hay suficientes datos para calcular de forma fiable el valor intrínseco de Parabilis Medicines Inc.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Análisis fundamental
Qué hace Parabilis Medicines
Parabilis Medicines Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Cambridge, Massachusetts and currently employs 145 full-time employees. The company went IPO on 2026-06-10. Parabilis Medicines, Inc., formerly FOG Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The company is built to develop transformative medicines addressing undruggable protein targets driving human disease.
- Sede central
- Estados Unidos de América US
- Empleados
- 145
- Fecha de salida a bolsa
- 10 jun., 2026
